News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Genentech, Inc.
NEWS
JOBS
IN THE PRESS
NEWS
Business
Genentech Gambles $310 Million+ on German Biotech BioNTech’s mRNA Cancer Vaccine Tech
September 21, 2016
·
2 min read
Drug Development
Cancer Drug Developed by Eliza Hall Institute, AbbVie and Genentech “Melts Away Cancer”
September 7, 2016
·
2 min read
Drug Development
Genentech’s Tecentriq Shows Positive Data in Phase III Trial, Has an Upcoming Action Date in October
September 1, 2016
·
3 min read
Job Trends
Biotechs are Expanding in the Bay Area Again: Bristol-Myers Squibb, Genentech, Gilead, Illumina and Verily and More
August 26, 2016
·
2 min read
Business
Led by Former Genentech Execs, Denali Banks $130 Million, Initiates Trial and Announces a Handful of Partnerships
August 25, 2016
·
3 min read
Drug Development
Genentech Receives a Blow After Lymphoma Drug Flunks Phase III Test
July 18, 2016
·
2 min read
Business
Employee Taken to Hospital After Genentech Hazmat Spill in South San Francisco
July 14, 2016
·
2 min read
Policy
Genentech, OSI Pharma to Fork Over $67 Million for Misleading Info About Cancer Drug Efficacy
June 7, 2016
·
2 min read
Drug Development
ASCO2016: Genentech’s TECENTRIQ Shrank Tumors in People with Previously Untreated Advanced Bladder Cancer
June 6, 2016
·
3 min read
AWARDS
JOBS
Currently, there are no jobs for this company on BioSpace
Browse all jobs
here
Oops!
There was an issue retrieving the jobs list. Please reload the page to view more jobs.
Title
Location
Company Name
Desc
View details
IN THE PRESS
Press Releases
FDA Grants Priority Review To Genentech’s Application for Enspryng, the First and Only At-Home Subcutaneous Treatment Option for Thyroid Eye Disease (TED)
June 30, 2026
·
10 min read
Press Releases
FDA Approves First Single-Dose Generic Treatment for Influenza
June 18, 2026
·
2 min read
Press Releases
FDA Grants Priority Review for Genentech’s Tecentriq for a Certain Type of Stage III Colon Cancer
June 11, 2026
·
14 min read
Press Releases
FDA Accepts New Drug Application for Genentech’s Giredestrant in ER-Positive Early-Stage Breast Cancer, the First and Only Oral SERD With Positive Phase III Results in the Curative Setting
June 2, 2026
·
7 min read
Press Releases
Genentech to Present New Data Advancing Its Obesity Portfolio at the American Diabetes Association’s 2026 Scientific Sessions
June 1, 2026
·
6 min read
Press Releases
Lupus Research Alliance and Genentech Fund Researchers Translating CAR T Success into Durable Lupus Treatments
May 26, 2026
·
5 min read
Press Releases
Genentech to Present New Data at ASCO 2026, Reinforcing Giredestrant’s Potential to Transform the Treatment Paradigm in Early Breast Cancer
May 19, 2026
·
19 min read
Press Releases
Roche to present new data at ASCO 2026, reinforcing giredestrant’s potential to transform the treatment paradigm in early breast cancer
May 19, 2026
·
12 min read
Press Releases
FDA Approves Genentech’s Tecentriq for Adjuvant Muscle-Invasive Bladder Cancer With ctDNA-Guided Treatment
May 17, 2026
·
10 min read
Press Releases
Genentech to Present Extensive Data Showcasing Its Industry-Leading Ophthalmology Portfolio at ARVO 2026
April 30, 2026
·
15 min read
